| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Martin Babler | President, CEO and Chairman, Director | Jun 27, 2024 | |||
| Mark Christopher Bradley | Chief Development Officer | Jun 27, 2024 | |||
| Jorn Drappa | Chief Medical Officer | Jun 27, 2024 | |||
| David M. Goldstein | Chief Scientific Officer | Jul 1, 2024 | |||
| Alan Colowick | Director | Jun 27, 2024 | |||
| Foresite Capital Management V, LLC | 10%+ Owner | Jul 1, 2024 | |||
| Roy C. Hardiman | Chief Business & Legal Officer | Jul 1, 2024 | |||
| AyurMaya Capital Management Company, LP | Director, Other*, 10%+ Owner | Jul 1, 2024 | |||
| Foresite Labs, LLC | 10%+ Owner | Jul 1, 2024 | |||
| James B. Tananbaum | Director, 10%+ Owner | Jul 1, 2024 | |||
| Sara Klein | General Counsel - Corp Secy | Jun 27, 2024 | |||
| Derrick Richardson | SVP, People and Culture | Jun 27, 2024 | |||
| Srinivas Akkaraju | Director | Jul 1, 2024 | |||
| Patrick Machado | Director | Jun 27, 2024 | |||
| John R. Schroer | Chief Financial Officer | Jun 27, 2024 | |||
| Sapna Srivastava | Director | Jun 27, 2024 | |||
| Zhengbin Yao | Director | Jun 27, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|